The Clorox Company $CLX Shares Sold by Legal & General Group Plc

Legal & General Group Plc reduced its position in The Clorox Company (NYSE:CLX) by 33.9% in the 4th quarter, Holdings Channel reports. The firm owned 683,533 shares of the company’s stock after selling 350,762 shares during the quarter. Legal & General Group Plc’s holdings in Clorox were worth $68,921,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CLX. Van ECK Associates Corp raised its stake in Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares during the last quarter. Invesco Ltd. raised its stake in Clorox by 23.1% in the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after purchasing an additional 750,415 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Clorox by 6,907.9% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after purchasing an additional 739,005 shares during the last quarter. Worldquant Millennium Advisors LLC acquired a new position in Clorox in the 2nd quarter valued at $71,856,000. Finally, Two Sigma Investments LP grew its holdings in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of Clorox stock opened at $89.98 on Friday. The business has a 50-day moving average of $98.46 and a 200 day moving average of $105.81. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The stock has a market capitalization of $10.88 billion, a price-to-earnings ratio of 14.61, a price-to-earnings-growth ratio of 0.50 and a beta of 0.59. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the business posted $1.45 EPS. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 5.61 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. JPMorgan Chase & Co. dropped their target price on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Evercore restated an “underperform” rating and issued a $110.00 target price on shares of Clorox in a report on Friday, May 1st. TD Cowen upped their target price on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Citigroup dropped their target price on Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a report on Friday, May 1st. Finally, Rothschild & Co Redburn set a $117.00 target price on Clorox in a report on Friday, February 13th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $103.40.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.63% of the stock is owned by corporate insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.